India’s leading in-vitro diagnostics company, Transasia Bio-Medicals Ltd. announced a Rs.50 crore investment in the expansion of its manufacturing facility in Sikkim.
The largest of its India manufacturing plants, Sikkim is the fourth one after Mumbai, Daman and Baddi. Also, the first ever diagnostics manufacturing facility in Northeast, the expanded facility will significantly enhance Transasia’s capacity to cater to the growing Indian and overseas market demands. Spread over 2 acres, the state of the art facility can produce 6000+ instruments monthly including the complete range of semi-automated analyzers.
“Sikkim is fast becoming a major hub for healthcare manufacturing with 14 major players already there. Transasia’s new facility will further reinforce this besides providing employment to local youth who otherwise would need to move out of the state for such quality opportunities. With this addition of capacity, we are well placed to deliver to the demand arising from continued growth posted by the company both in Indian and overseas markets,” said Suresh Vazirani, chairman & managing director, Transasia Bio-Medicals Ltd.
Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro diagnostic company offers products and solutions in biochemistry, haematology, coagulation, ESR, immunology, urinalysis, critical care, diabetes management, microbiology and molecular diagnostics. It provides doctors and patients with reliable, affordable and innovative medical diagnostic systems, with 65,000 equipment installed across India.